Back
IGM Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
40
IGMS
IGM Biosciences
Last Price:
15.38
Seasonality Move:
-15.39%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-19.92%
Sell
40
IGM Biosciences (IGMS)
is a Sell
Is IGM Biosciences a Buy, Sell or Hold?
- The current IGM Biosciences [IGMS] share price is $15.41. The Score for IGMS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- IGMS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGMS Stock Price Chart
What is IGM Biosciences's stock price today?
-
The IGM Biosciences share price today is $15.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGMS is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
IGMS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.12 | Buy |
Relative Strength Index (14 RSI): | 56.84 | Buy |
Chaikin Money Flow: | -111439 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.13 - 16.77) | Buy |
Bollinger Bands (100): | (7.34 - 13.14) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 55.73 | Buy |
Chaikin Money Flow: | -66635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.46 - 0.7) | Buy |
Bollinger Bands (100): | (0.33 - 3.11) | Sell |
IGMS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.64 | Sell |
20-day SMA: | 14.94 | Buy |
50-day SMA: | 11.86 | Buy |
200-day SMA: | 10.36 | Buy |
8-day EMA: | 15.39 | Buy |
20-day EMA: | 14.66 | Buy |
50-day EMA: | 12.68 | Buy |
200-day EMA: | 10.59 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.71 | Buy |
20-day SMA: | 0.61 | Buy |
50-day SMA: | 0.55 | Buy |
200-day SMA: | 3.29 | Sell |
8-day EMA: | 0.7 | Buy |
20-day EMA: | 0.65 | Buy |
50-day EMA: | 0.87 | Sell |
200-day EMA: | 7.55 | Sell |
IGM Biosciences Earnings Growth & IGMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and an increase next year of $0.75 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
IGM Biosciences Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |